Consensus Inari Medical, Inc.

Equities

NARI

US45332Y1091

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
49.95 ^USD	+5.29%		+9.18%	-23.06%

May. 23	Sector Update: Health Care Stocks Lower Thursday Afternoon	MT
May. 23	Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement	MT

Evolution of the average Target Price on Inari Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7162213c431.anU8ao4x2cz8BNaHVqMzlP8e6fd2NUPQMc2AIvTAZ-A.CUBYBcFwib2_Q67vPOxw-pRHoLshATeBS6XwcsKVIqUTIFoJ_XKOlqlUpQ~517f955464627af120dabb2c178c8ad2

Analyst Recommendations on Inari Medical, Inc.

Inari Medical Insider Sold Shares Worth $1,863,977, According to a Recent SEC Filing	May. 20	MT
Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing	May. 03	MT
Truist Securities Cuts Inari Medical's Price Target to $52 From $61, Reiterates Hold Rating	Mar. 22	MT
Piper Sandler Downgrades Inari Medical to Neutral From Overweight, Cuts Price Target to $55 From $85	Feb. 29	MT
Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating	Feb. 29	MT
Needham Initiates Inari Medical With Buy Rating, $72 PT; Notes 'Attractive' Valuation, Expects 'Rapid' Improvement in Margin, Earnings in 2025, Beyond	Jan. 23	MT
Truist Securities Adjusts Price Target on Inari Medical to $70 From $65, Maintains Hold Rating	Dec. 22	MT
Truist Securities Adjusts Inari Medical's Price Target to $65 From $70, Keeps Hold Rating	23-07-19	MT
Baird Initiates Inari Medical With Outperform Rating, $79 Price Target	23-07-19	MT
Truist Securities Adjusts Price Target on Inari Medical to $70 From $68, Keeps Hold Rating	23-04-18	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $80 From $77, Maintains Buy Rating	23-02-28	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $77 From $76, Maintains Buy Rating	23-02-21	MT
Truist Securities Adjusts Inari Medical's Price Target to $65 From $75, Maintains Hold Rating	23-01-31	MT
Jefferies Adjusts Inari Medical's Price Target to $91 From $89, Maintains Buy Rating	23-01-12	MT
Morgan Stanley Cuts Price Target on Inari Medical to $83 From $95, Affirms Overweight Rating	23-01-06	MT
Truist Securities Adjusts Price Target on Inari Medical to $75 From $84, Maintains Hold Rating	22-12-20	MT
Morgan Stanley Adjusts Price Target on Inari Medical to $95 From $93, Maintains Overweight Rating	22-11-03	MT
Berenberg Bank Adjusts Inari Medical Price Target to $86 From $85, Maintains Buy Rating	22-11-03	MT
BTIG Trims Inari Medical's Price Target to $97 From $100, Maintains Buy Rating	22-10-17	MT
Truist Securities Adjusts Price Target on Inari Medical to $80 From $87, Maintains Hold Rating	22-10-17	MT
Jefferies Starts Inari Medical at Buy With $88 Price Target	22-10-12	MT
Berenberg Bank Initiates Coverage on Inari Medical With Buy Rating, $85 Price Target	22-09-29	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $94 From $92, Reiterates Buy Rating	22-09-16	MT
Truist Securities Initiates Inari Medical at Hold With $87 Price Target	22-09-13	MT
Morgan Stanley Lowers Inari Medical's Price Target to $93 From $108, Maintains Overweight Rating	22-07-15	MT